Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 2
1948 5
1949 3
1950 1
1951 3
1952 5
1953 4
1954 1
1955 4
1956 3
1957 2
1958 1
1959 1
1960 1
1961 1
1962 2
1966 1
1968 2
1972 1
1973 1
1974 2
1975 1
1976 1
1977 1
1979 1
1980 1
1981 2
1982 8
1983 6
1984 7
1985 5
1986 13
1987 9
1988 8
1989 10
1990 16
1991 12
1992 15
1993 12
1994 18
1995 30
1996 26
1997 22
1998 15
1999 35
2000 31
2001 35
2002 40
2003 28
2004 35
2005 48
2006 51
2007 41
2008 46
2009 42
2010 58
2011 73
2012 73
2013 91
2014 88
2015 79
2016 98
2017 98
2018 121
2019 105
2020 96
Text availability
Article attribute
Article type
Publication date

Search Results

1,540results
Results by year
Filters applied:.Clear all
Page 1
安全性和多目标的抗肿瘤活性Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J,Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson AD, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG. Drilon A, et al. Among authors:bauer tm. 癌症Discov. 2017 Apr;7(4):400-409. doi: 10.1158/2159-8290.CD-16-1237. Epub 2017 Feb 9. 癌症Discov. 2017. PMID:28183697 Free PMC article. Clinical Trial.
[Acute coronary syndrome].
Leschik J,Bauer T. Leschik J, et al. Among authors:bauer t. MMW Fortschr Med. 2018 Aug;160(14):52-61. doi: 10.1007/s15006-018-0022-2. MMW Fortschr Med. 2018. PMID:30105733 German. No abstract available.
Functional classification of memory CD8(+) T cells by CX3CR1 expression.
Böttcher JP, Beyer M, Meissner F, Abdullah Z, Sander J, Höchst B, Eickhoff S, Rieckmann JC, Russo C,Bauer T, Flecken T, Giesen D, Engel D, Jung S, Busch DH, Protzer U, Thimme R, Mann M, Kurts C, Schultze JL, Kastenmüller W, Knolle PA. Böttcher JP, et al. Among authors:bauer t. Nat Commun. 2015 Sep 25;6:8306. doi: 10.1038/ncomms9306. Nat Commun. 2015. PMID:26404698 Free PMC article.
T细胞受体移植允许病毒学控制器l of Hepatitis B virus infection.
Wisskirchen K, Kah J, Malo A, Asen T, Volz T, Allweiss L, Wettengel JM, Lütgehetmann M, Urban S,Bauer T, Dandri M, Protzer U. Wisskirchen K, et al. Among authors:bauer t. J Clin Invest. 2019 Apr 30;129(7):2932-2945. doi: 10.1172/JCI120228. J Clin Invest. 2019. PMID:31039136 Free PMC article.
Clinical Management of Adverse Events Associated with Lorlatinib.
Bauer TM, Felip E, Solomon BJ, Thurm H, Peltz G, Chioda MD, Shaw AT. Bauer TM, et al. Oncologist. 2019 Aug;24(8):1103-1110. doi: 10.1634/theoncologist.2018-0380. Epub 2019 Mar 19. Oncologist. 2019. PMID:30890623 Free PMC article.
Plasma protein patterns as comprehensive indicators of health.
Williams SA, Kivimaki M, Langenberg C, Hingorani AD, Casas JP, Bouchard C, Jonasson C, Sarzynski MA, Shipley MJ, Alexander L, Ash J,Bauer T, Chadwick J, Datta G, DeLisle RK, Hagar Y, Hinterberg M, Ostroff R, Weiss S, Ganz P, Wareham NJ. Williams SA, et al. Among authors:bauer t. Nat Med. 2019 Dec;25(12):1851-1857. doi: 10.1038/s41591-019-0665-2. Epub 2019 Dec 2. Nat Med. 2019. PMID:31792462 Free PMC article.
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial.
Shaw AT, Felip E,Bauer TM, Besse B, Navarro A, Postel-Vinay S, Gainor JF, Johnson M, Dietrich J, James LP, Clancy JS, Chen J, Martini JF, Abbattista A, Solomon BJ. Shaw AT, et al. Among authors:bauer tm. Lancet Oncol. 2017 Dec;18(12):1590-1599. doi: 10.1016/S1470-2045(17)30680-0. Epub 2017 Oct 23. Lancet Oncol. 2017. PMID:29074098 Free PMC article. Clinical Trial.
Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth.
Nagdas S, Kashatus JA, Nascimento A, Hussain SS, Trainor RE, Pollock SR, Adair SJ, Michaels AD, Sesaki H, Stelow EB,Bauer TW, Kashatus DF. Nagdas S, et al. Among authors:bauer tw. Cell Rep. 2019 Aug 13;28(7):1845-1859.e5. doi: 10.1016/j.celrep.2019.07.031. Cell Rep. 2019. PMID:31412251 Free PMC article.
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.
Amin A, Plimack ER, Ernstoff MS, Lewis LD,Bauer TM, McDermott DF, Carducci M, Kollmannsberger C, Rini BI, Heng DYC, Knox J, Voss MH, Spratlin J, Berghorn E, Yang L, Hammers HJ. Amin A, et al. Among authors:bauer tm. J Immunother Cancer. 2018 Oct 22;6(1):109. doi: 10.1186/s40425-018-0420-0. J Immunother Cancer. 2018. PMID:30348216 Free PMC article. Clinical Trial.
Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study.
Hong DS,Bauer TM, Lee JJ, Dowlati A, Brose MS, Farago AF, Taylor M, Shaw AT, Montez S, Meric-Bernstam F, Smith S, Tuch BB, Ebata K, Cruickshank S, Cox MC, Burris HA 3rd, Doebele RC. Hong DS, et al. Among authors:bauer tm. Ann Oncol. 2019 Feb 1;30(2):325-331. doi: 10.1093/annonc/mdy539. Ann Oncol. 2019. PMID:30624546 Free PMC article. Clinical Trial.
1,540results
Jumpto page
Feedback